Global Nuclear Medicine Market Research Report 2022 Professional Edition
The global Nuclear Medicine market was valued at 456.88 Million USD in 2021 and will grow with a CAGR of 7.2% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015. Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.
By Market Verdors:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
By Types:
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
By Applications:
Diagnostic
Therapeutic
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015. Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.
By Market Verdors:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
By Types:
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
By Applications:
Diagnostic
Therapeutic
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nuclear Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Tc-99
1.4.3 I-123/131
1.4.4 In-111
1.4.5 Xe-133
1.4.6 Th-201
1.4.7 Ga-67
1.5 Market by Application
1.5.1 Global Nuclear Medicine Market Share by Application: 2022-2027
1.5.2 Diagnostic
1.5.3 Therapeutic
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Nuclear Medicine Market
1.8.1 Global Nuclear Medicine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Nuclear Medicine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Nuclear Medicine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nuclear Medicine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nuclear Medicine Production Sites, Area Served, Product Type
3 SALES BY REGION
3.1 Global Nuclear Medicine Sales Volume Market Share by Region (2016-2021)
3.2 Global Nuclear Medicine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Nuclear Medicine Sales Volume
3.3.1 North America Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Nuclear Medicine Sales Volume
3.4.1 East Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Nuclear Medicine Sales Volume (2016-2021)
3.5.1 Europe Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Nuclear Medicine Sales Volume (2016-2021)
3.6.1 South Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Nuclear Medicine Sales Volume (2016-2021)
3.7.1 Southeast Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Nuclear Medicine Sales Volume (2016-2021)
3.8.1 Middle East Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Nuclear Medicine Sales Volume (2016-2021)
3.9.1 Africa Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Nuclear Medicine Sales Volume (2016-2021)
3.10.1 Oceania Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Nuclear Medicine Sales Volume (2016-2021)
3.11.1 South America Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Nuclear Medicine Sales Volume (2016-2021)
3.12.1 Rest of the World Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 NORTH AMERICA
4.1 North America Nuclear Medicine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 EAST ASIA
5.1 East Asia Nuclear Medicine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 EUROPE
6.1 Europe Nuclear Medicine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 SOUTH ASIA
7.1 South Asia Nuclear Medicine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 SOUTHEAST ASIA
8.1 Southeast Asia Nuclear Medicine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 MIDDLE EAST
9.1 Middle East Nuclear Medicine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 AFRICA
10.1 Africa Nuclear Medicine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 OCEANIA
11.1 Oceania Nuclear Medicine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 SOUTH AMERICA
12.1 South America Nuclear Medicine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 REST OF THE WORLD
13.1 Rest of the World Nuclear Medicine Consumption by Countries
13.2 Kazakhstan
14 SALES VOLUME, SALES REVENUE, SALES PRICE TREND BY TYPE
14.1 Global Nuclear Medicine Sales Volume Market Share by Type (2016-2021)
14.2 Global Nuclear Medicine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Nuclear Medicine Sales Price by Type (2016-2021)
15 CONSUMPTION ANALYSIS BY APPLICATION
15.1 Global Nuclear Medicine Consumption Volume by Application (2016-2021)
15.2 Global Nuclear Medicine Consumption Value by Application (2016-2021)
16 COMPANY PROFILES AND KEY FIGURES IN NUCLEAR MEDICINE BUSINESS
16.1 GE Healthcare
16.1.1 GE Healthcare Company Profile
16.1.2 GE Healthcare Nuclear Medicine Product Specification
16.1.3 GE Healthcare Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Bracco Imaging
16.2.1 Bracco Imaging Company Profile
16.2.2 Bracco Imaging Nuclear Medicine Product Specification
16.2.3 Bracco Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Mallinckrodt
16.3.1 Mallinckrodt Company Profile
16.3.2 Mallinckrodt Nuclear Medicine Product Specification
16.3.3 Mallinckrodt Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Lantheus Medical Imaging
16.4.1 Lantheus Medical Imaging Company Profile
16.4.2 Lantheus Medical Imaging Nuclear Medicine Product Specification
16.4.3 Lantheus Medical Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Bayer
16.5.1 Bayer Company Profile
16.5.2 Bayer Nuclear Medicine Product Specification
16.5.3 Bayer Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Triad Isotopes
16.6.1 Triad Isotopes Company Profile
16.6.2 Triad Isotopes Nuclear Medicine Product Specification
16.6.3 Triad Isotopes Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Nordion
16.7.1 Nordion Company Profile
16.7.2 Nordion Nuclear Medicine Product Specification
16.7.3 Nordion Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Jubilant Pharma
16.8.1 Jubilant Pharma Company Profile
16.8.2 Jubilant Pharma Nuclear Medicine Product Specification
16.8.3 Jubilant Pharma Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Eli Lilly
16.9.1 Eli Lilly Company Profile
16.9.2 Eli Lilly Nuclear Medicine Product Specification
16.9.3 Eli Lilly Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 SIEMENS
16.10.1 SIEMENS Company Profile
16.10.2 SIEMENS Nuclear Medicine Product Specification
16.10.3 SIEMENS Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 China Isotope & Radiation
16.11.1 China Isotope & Radiation Company Profile
16.11.2 China Isotope & Radiation Nuclear Medicine Product Specification
16.11.3 China Isotope & Radiation Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Dongcheng
16.12.1 Dongcheng Company Profile
16.12.2 Dongcheng Nuclear Medicine Product Specification
16.12.3 Dongcheng Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 NUCLEAR MEDICINE MANUFACTURING COST ANALYSIS
17.1 Nuclear Medicine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Nuclear Medicine
17.4 Nuclear Medicine Industrial Chain Analysis
18 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
18.1 Marketing Channel
18.2 Nuclear Medicine Distributors List
18.3 Nuclear Medicine Customers
19 MARKET DYNAMICS
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 PRODUCTION AND SUPPLY FORECAST
20.1 Global Forecasted Production of Nuclear Medicine (2022-2027)
20.2 Global Forecasted Revenue of Nuclear Medicine (2022-2027)
20.3 Global Forecasted Price of Nuclear Medicine (2016-2027)
20.4 Global Forecasted Production of Nuclear Medicine by Region (2022-2027)
20.4.1 North America Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.9 South America Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Nuclear Medicine by Application (2022-2027)
21 CONSUMPTION AND DEMAND FORECAST
21.1 North America Forecasted Consumption of Nuclear Medicine by Country
21.2 East Asia Market Forecasted Consumption of Nuclear Medicine by Country
21.3 Europe Market Forecasted Consumption of Nuclear Medicine by Countriy
21.4 South Asia Forecasted Consumption of Nuclear Medicine by Country
21.5 Southeast Asia Forecasted Consumption of Nuclear Medicine by Country
21.6 Middle East Forecasted Consumption of Nuclear Medicine by Country
21.7 Africa Forecasted Consumption of Nuclear Medicine by Country
21.8 Oceania Forecasted Consumption of Nuclear Medicine by Country
21.9 South America Forecasted Consumption of Nuclear Medicine by Country
21.10 Rest of the world Forecasted Consumption of Nuclear Medicine by Country
22 RESEARCH FINDINGS AND CONCLUSION
23 METHODOLOGY AND DATA SOURCE
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nuclear Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Tc-99
1.4.3 I-123/131
1.4.4 In-111
1.4.5 Xe-133
1.4.6 Th-201
1.4.7 Ga-67
1.5 Market by Application
1.5.1 Global Nuclear Medicine Market Share by Application: 2022-2027
1.5.2 Diagnostic
1.5.3 Therapeutic
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Nuclear Medicine Market
1.8.1 Global Nuclear Medicine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Nuclear Medicine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Nuclear Medicine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nuclear Medicine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nuclear Medicine Production Sites, Area Served, Product Type
3 SALES BY REGION
3.1 Global Nuclear Medicine Sales Volume Market Share by Region (2016-2021)
3.2 Global Nuclear Medicine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Nuclear Medicine Sales Volume
3.3.1 North America Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Nuclear Medicine Sales Volume
3.4.1 East Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Nuclear Medicine Sales Volume (2016-2021)
3.5.1 Europe Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Nuclear Medicine Sales Volume (2016-2021)
3.6.1 South Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Nuclear Medicine Sales Volume (2016-2021)
3.7.1 Southeast Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Nuclear Medicine Sales Volume (2016-2021)
3.8.1 Middle East Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Nuclear Medicine Sales Volume (2016-2021)
3.9.1 Africa Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Nuclear Medicine Sales Volume (2016-2021)
3.10.1 Oceania Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Nuclear Medicine Sales Volume (2016-2021)
3.11.1 South America Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Nuclear Medicine Sales Volume (2016-2021)
3.12.1 Rest of the World Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 NORTH AMERICA
4.1 North America Nuclear Medicine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 EAST ASIA
5.1 East Asia Nuclear Medicine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 EUROPE
6.1 Europe Nuclear Medicine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 SOUTH ASIA
7.1 South Asia Nuclear Medicine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 SOUTHEAST ASIA
8.1 Southeast Asia Nuclear Medicine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 MIDDLE EAST
9.1 Middle East Nuclear Medicine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 AFRICA
10.1 Africa Nuclear Medicine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 OCEANIA
11.1 Oceania Nuclear Medicine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 SOUTH AMERICA
12.1 South America Nuclear Medicine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 REST OF THE WORLD
13.1 Rest of the World Nuclear Medicine Consumption by Countries
13.2 Kazakhstan
14 SALES VOLUME, SALES REVENUE, SALES PRICE TREND BY TYPE
14.1 Global Nuclear Medicine Sales Volume Market Share by Type (2016-2021)
14.2 Global Nuclear Medicine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Nuclear Medicine Sales Price by Type (2016-2021)
15 CONSUMPTION ANALYSIS BY APPLICATION
15.1 Global Nuclear Medicine Consumption Volume by Application (2016-2021)
15.2 Global Nuclear Medicine Consumption Value by Application (2016-2021)
16 COMPANY PROFILES AND KEY FIGURES IN NUCLEAR MEDICINE BUSINESS
16.1 GE Healthcare
16.1.1 GE Healthcare Company Profile
16.1.2 GE Healthcare Nuclear Medicine Product Specification
16.1.3 GE Healthcare Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Bracco Imaging
16.2.1 Bracco Imaging Company Profile
16.2.2 Bracco Imaging Nuclear Medicine Product Specification
16.2.3 Bracco Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Mallinckrodt
16.3.1 Mallinckrodt Company Profile
16.3.2 Mallinckrodt Nuclear Medicine Product Specification
16.3.3 Mallinckrodt Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Lantheus Medical Imaging
16.4.1 Lantheus Medical Imaging Company Profile
16.4.2 Lantheus Medical Imaging Nuclear Medicine Product Specification
16.4.3 Lantheus Medical Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Bayer
16.5.1 Bayer Company Profile
16.5.2 Bayer Nuclear Medicine Product Specification
16.5.3 Bayer Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Triad Isotopes
16.6.1 Triad Isotopes Company Profile
16.6.2 Triad Isotopes Nuclear Medicine Product Specification
16.6.3 Triad Isotopes Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Nordion
16.7.1 Nordion Company Profile
16.7.2 Nordion Nuclear Medicine Product Specification
16.7.3 Nordion Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Jubilant Pharma
16.8.1 Jubilant Pharma Company Profile
16.8.2 Jubilant Pharma Nuclear Medicine Product Specification
16.8.3 Jubilant Pharma Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Eli Lilly
16.9.1 Eli Lilly Company Profile
16.9.2 Eli Lilly Nuclear Medicine Product Specification
16.9.3 Eli Lilly Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 SIEMENS
16.10.1 SIEMENS Company Profile
16.10.2 SIEMENS Nuclear Medicine Product Specification
16.10.3 SIEMENS Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 China Isotope & Radiation
16.11.1 China Isotope & Radiation Company Profile
16.11.2 China Isotope & Radiation Nuclear Medicine Product Specification
16.11.3 China Isotope & Radiation Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Dongcheng
16.12.1 Dongcheng Company Profile
16.12.2 Dongcheng Nuclear Medicine Product Specification
16.12.3 Dongcheng Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 NUCLEAR MEDICINE MANUFACTURING COST ANALYSIS
17.1 Nuclear Medicine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Nuclear Medicine
17.4 Nuclear Medicine Industrial Chain Analysis
18 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
18.1 Marketing Channel
18.2 Nuclear Medicine Distributors List
18.3 Nuclear Medicine Customers
19 MARKET DYNAMICS
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 PRODUCTION AND SUPPLY FORECAST
20.1 Global Forecasted Production of Nuclear Medicine (2022-2027)
20.2 Global Forecasted Revenue of Nuclear Medicine (2022-2027)
20.3 Global Forecasted Price of Nuclear Medicine (2016-2027)
20.4 Global Forecasted Production of Nuclear Medicine by Region (2022-2027)
20.4.1 North America Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.9 South America Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Nuclear Medicine by Application (2022-2027)
21 CONSUMPTION AND DEMAND FORECAST
21.1 North America Forecasted Consumption of Nuclear Medicine by Country
21.2 East Asia Market Forecasted Consumption of Nuclear Medicine by Country
21.3 Europe Market Forecasted Consumption of Nuclear Medicine by Countriy
21.4 South Asia Forecasted Consumption of Nuclear Medicine by Country
21.5 Southeast Asia Forecasted Consumption of Nuclear Medicine by Country
21.6 Middle East Forecasted Consumption of Nuclear Medicine by Country
21.7 Africa Forecasted Consumption of Nuclear Medicine by Country
21.8 Oceania Forecasted Consumption of Nuclear Medicine by Country
21.9 South America Forecasted Consumption of Nuclear Medicine by Country
21.10 Rest of the world Forecasted Consumption of Nuclear Medicine by Country
22 RESEARCH FINDINGS AND CONCLUSION
23 METHODOLOGY AND DATA SOURCE
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
LIST OF TABLES AND FIGURES
Key Players Covered: Ranking by Nuclear Medicine Revenue (US$ Million) 2016-2021
Global Nuclear Medicine Market Size by Type (US$ Million): 2022-2027
Global Nuclear Medicine Market Size by Application (US$ Million): 2022-2027
Global Nuclear Medicine Production Capacity by Manufacturers
Global Nuclear Medicine Production by Manufacturers (2016-2021)
Global Nuclear Medicine Production Market Share by Manufacturers (2016-2021)
Global Nuclear Medicine Revenue by Manufacturers (2016-2021)
Global Nuclear Medicine Revenue Share by Manufacturers (2016-2021)
Global Market Nuclear Medicine Average Price of Key Manufacturers (2016-2021)
Manufacturers Nuclear Medicine Production Sites and Area Served
Manufacturers Nuclear Medicine Product Type
Global Nuclear Medicine Sales Volume by Region (2016-2021)
Global Nuclear Medicine Sales Volume Market Share by Region (2016-2021)
Global Nuclear Medicine Sales Revenue by Region (2016-2021)
Global Nuclear Medicine Sales Revenue Market Share by Region (2016-2021)
North America Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Nuclear Medicine Consumption by Countries (2016-2021)
East Asia Nuclear Medicine Consumption by Countries (2016-2021)
Europe Nuclear Medicine Consumption by Region (2016-2021)
South Asia Nuclear Medicine Consumption by Countries (2016-2021)
Southeast Asia Nuclear Medicine Consumption by Countries (2016-2021)
Middle East Nuclear Medicine Consumption by Countries (2016-2021)
Africa Nuclear Medicine Consumption by Countries (2016-2021)
Oceania Nuclear Medicine Consumption by Countries (2016-2021)
South America Nuclear Medicine Consumption by Countries (2016-2021)
Rest of the World Nuclear Medicine Consumption by Countries (2016-2021)
Global Nuclear Medicine Sales Volume by Type (2016-2021)
Global Nuclear Medicine Sales Volume Market Share by Type (2016-2021)
Global Nuclear Medicine Sales Revenue by Type (2016-2021)
Global Nuclear Medicine Sales Revenue Share by Type (2016-2021)
Global Nuclear Medicine Sales Price by Type (2016-2021)
Global Nuclear Medicine Consumption Volume by Application (2016-2021)
Global Nuclear Medicine Consumption Volume Market Share by Application (2016-2021)
Global Nuclear Medicine Consumption Value by Application (2016-2021)
Global Nuclear Medicine Consumption Value Market Share by Application (2016-2021)
GE Healthcare Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bracco Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Mallinckrodt Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Lantheus Medical Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bayer Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Triad Isotopes Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Nordion Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Jubilant Pharma Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eli Lilly Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
SIEMENS Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
China Isotope & Radiation Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Dongcheng Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Nuclear Medicine Distributors List
Nuclear Medicine Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Nuclear Medicine Production Forecast by Region (2022-2027)
Global Nuclear Medicine Sales Volume Forecast by Type (2022-2027)
Global Nuclear Medicine Sales Volume Market Share Forecast by Type (2022-2027)
Global Nuclear Medicine Sales Revenue Forecast by Type (2022-2027)
Global Nuclear Medicine Sales Revenue Market Share Forecast by Type (2022-2027)
Global Nuclear Medicine Sales Price Forecast by Type (2022-2027)
Global Nuclear Medicine Consumption Volume Forecast by Application (2022-2027)
Global Nuclear Medicine Consumption Value Forecast by Application (2022-2027)
North America Nuclear Medicine Consumption Forecast 2022-2027 by Country
East Asia Nuclear Medicine Consumption Forecast 2022-2027 by Country
Europe Nuclear Medicine Consumption Forecast 2022-2027 by Country
South Asia Nuclear Medicine Consumption Forecast 2022-2027 by Country
Southeast Asia Nuclear Medicine Consumption Forecast 2022-2027 by Country
Middle East Nuclear Medicine Consumption Forecast 2022-2027 by Country
Africa Nuclear Medicine Consumption Forecast 2022-2027 by Country
Oceania Nuclear Medicine Consumption Forecast 2022-2027 by Country
South America Nuclear Medicine Consumption Forecast 2022-2027 by Country
Rest of the world Nuclear Medicine Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Nuclear Medicine Market Share by Type: 2021 VS 2027
Tc-99 Features
I-123/131 Features
In-111 Features
Xe-133 Features
Th-201 Features
Ga-67 Features
Global Nuclear Medicine Market Share by Application: 2021 VS 2027
Diagnostic Case Studies
Therapeutic Case Studies
Nuclear Medicine Report Years Considered
Global Nuclear Medicine Market Status and Outlook (2016-2027)
North America Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
East Asia Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Europe Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South Asia Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South America Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Middle East Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Africa Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Oceania Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South America Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
North America Nuclear Medicine Sales Volume Growth Rate (2016-2021)
East Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Europe Nuclear Medicine Sales Volume Growth Rate (2016-2021)
South Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Southeast Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Middle East Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Africa Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Oceania Nuclear Medicine Sales Volume Growth Rate (2016-2021)
South America Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Rest of the World Nuclear Medicine Sales Volume Growth Rate (2016-2021)
North America Nuclear Medicine Consumption and Growth Rate (2016-2021)
North America Nuclear Medicine Consumption Market Share by Countries in 2021
United States Nuclear Medicine Consumption and Growth Rate (2016-2021)
Canada Nuclear Medicine Consumption and Growth Rate (2016-2021)
Mexico Nuclear Medicine Consumption and Growth Rate (2016-2021)
East Asia Nuclear Medicine Consumption and Growth Rate (2016-2021)
East Asia Nuclear Medicine Consumption Market Share by Countries in 2021
China Nuclear Medicine Consumption and Growth Rate (2016-2021)
Japan Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Korea Nuclear Medicine Consumption and Growth Rate (2016-2021)
Europe Nuclear Medicine Consumption and Growth Rate
Europe Nuclear Medicine Consumption Market Share by Region in 2021
Germany Nuclear Medicine Consumption and Growth Rate (2016-2021)
United Kingdom Nuclear Medicine Consumption and Growth Rate (2016-2021)
France Nuclear Medicine Consumption and Growth Rate (2016-2021)
Italy Nuclear Medicine Consumption and Growth Rate (2016-2021)
Russia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Spain Nuclear Medicine Consumption and Growth Rate (2016-2021)
Netherlands Nuclear Medicine Consumption and Growth Rate (2016-2021)
Switzerland Nuclear Medicine Consumption and Growth Rate (2016-2021)
Poland Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Asia Nuclear Medicine Consumption and Growth Rate
South Asia Nuclear Medicine Consumption Market Share by Countries in 2021
India Nuclear Medicine Consumption and Growth Rate (2016-2021)
Pakistan Nuclear Medicine Consumption and Growth Rate (2016-2021)
Bangladesh Nuclear Medicine Consumption and Growth Rate (2016-2021)
Southeast Asia Nuclear Medicine Consumption and Growth Rate
Southeast Asia Nuclear Medicine Consumption Market Share by Countries in 2021
Indonesia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Thailand Nuclear Medicine Consumption and Growth Rate (2016-2021)
Singapore Nuclear Medicine Consumption and Growth Rate (2016-2021)
Malaysia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Philippines Nuclear Medicine Consumption and Growth Rate (2016-2021)
Vietnam Nuclear Medicine Consumption and Growth Rate (2016-2021)
Myanmar Nuclear Medicine Consumption and Growth Rate (2016-2021)
Middle East Nuclear Medicine Consumption and Growth Rate
Middle East Nuclear Medicine Consumption Market Share by Countries in 2021
Turkey Nuclear Medicine Consumption and Growth Rate (2016-2021)
Saudi Arabia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Iran Nuclear Medicine Consumption and Growth Rate (2016-2021)
United Arab Emirates Nuclear Medicine Consumption and Growth Rate (2016-2021)
Israel Nuclear Medicine Consumption and Growth Rate (2016-2021)
Iraq Nuclear Medicine Consumption and Growth Rate (2016-2021)
Qatar Nuclear Medicine Consumption and Growth Rate (2016-2021)
Kuwait Nuclear Medicine Consumption and Growth Rate (2016-2021)
Oman Nuclear Medicine Consumption and Growth Rate (2016-2021)
Africa Nuclear Medicine Consumption and Growth Rate
Africa Nuclear Medicine Consumption Market Share by Countries in 2021
Nigeria Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Africa Nuclear Medicine Consumption and Growth Rate (2016-2021)
Egypt Nuclear Medicine Consumption and Growth Rate (2016-2021)
Algeria Nuclear Medicine Consumption and Growth Rate (2016-2021)
Morocco Nuclear Medicine Consumption and Growth Rate (2016-2021)
Oceania Nuclear Medicine Consumption and Growth Rate
Oceania Nuclear Medicine Consumption Market Share by Countries in 2021
Australia Nuclear Medicine Consumption and Growth Rate (2016-2021)
New Zealand Nuclear Medicine Consumption and Growth Rate (2016-2021)
South America Nuclear Medicine Consumption and Growth Rate
South America Nuclear Medicine Consumption Market Share by Countries in 2021
Brazil Nuclear Medicine Consumption and Growth Rate (2016-2021)
Argentina Nuclear Medicine Consumption and Growth Rate (2016-2021)
Columbia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Chile Nuclear Medicine Consumption and Growth Rate (2016-2021)
Venezuelal Nuclear Medicine Consumption and Growth Rate (2016-2021)
Peru Nuclear Medicine Consumption and Growth Rate (2016-2021)
Puerto Rico Nuclear Medicine Consumption and Growth Rate (2016-2021)
Ecuador Nuclear Medicine Consumption and Growth Rate (2016-2021)
Rest of the World Nuclear Medicine Consumption and Growth Rate
Rest of the World Nuclear Medicine Consumption Market Share by Countries in 2021
Kazakhstan Nuclear Medicine Consumption and Growth Rate (2016-2021)
Sales Market Share of Nuclear Medicine by Type in 2021
Sales Revenue Market Share of Nuclear Medicine by Type in 2021
Global Nuclear Medicine Consumption Volume Market Share by Application in 2021
GE Healthcare Nuclear Medicine Product Specification
Bracco Imaging Nuclear Medicine Product Specification
Mallinckrodt Nuclear Medicine Product Specification
Lantheus Medical Imaging Nuclear Medicine Product Specification
Bayer Nuclear Medicine Product Specification
Triad Isotopes Nuclear Medicine Product Specification
Nordion Nuclear Medicine Product Specification
Jubilant Pharma Nuclear Medicine Product Specification
Eli Lilly Nuclear Medicine Product Specification
SIEMENS Nuclear Medicine Product Specification
China Isotope & Radiation Nuclear Medicine Product Specification
Dongcheng Nuclear Medicine Product Specification
Manufacturing Cost Structure of Nuclear Medicine
Manufacturing Process Analysis of Nuclear Medicine
Nuclear Medicine Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Nuclear Medicine Production Capacity Growth Rate Forecast (2022-2027)
Global Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Global Nuclear Medicine Price and Trend Forecast (2016-2027)
North America Nuclear Medicine Production Growth Rate Forecast (2022-2027)
North America Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
East Asia Nuclear Medicine Production Growth Rate Forecast (2022-2027)
East Asia Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Europe Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Europe Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
South Asia Nuclear Medicine Production Growth Rate Forecast (2022-2027)
South Asia Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Southeast Asia Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Middle East Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Middle East Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Africa Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Africa Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Oceania Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Oceania Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
South America Nuclear Medicine Production Growth Rate Forecast (2022-2027)
South America Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Rest of the World Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Rest of the World Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
North America Nuclear Medicine Consumption Forecast 2022-2027
East Asia Nuclear Medicine Consumption Forecast 2022-2027
Europe Nuclear Medicine Consumption Forecast 2022-2027
South Asia Nuclear Medicine Consumption Forecast 2022-2027
Southeast Asia Nuclear Medicine Consumption Forecast 2022-2027
Middle East Nuclear Medicine Consumption Forecast 2022-2027
Africa Nuclear Medicine Consumption Forecast 2022-2027
Oceania Nuclear Medicine Consumption Forecast 2022-2027
South America Nuclear Medicine Consumption Forecast 2022-2027
Rest of the world Nuclear Medicine Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
Key Players Covered: Ranking by Nuclear Medicine Revenue (US$ Million) 2016-2021
Global Nuclear Medicine Market Size by Type (US$ Million): 2022-2027
Global Nuclear Medicine Market Size by Application (US$ Million): 2022-2027
Global Nuclear Medicine Production Capacity by Manufacturers
Global Nuclear Medicine Production by Manufacturers (2016-2021)
Global Nuclear Medicine Production Market Share by Manufacturers (2016-2021)
Global Nuclear Medicine Revenue by Manufacturers (2016-2021)
Global Nuclear Medicine Revenue Share by Manufacturers (2016-2021)
Global Market Nuclear Medicine Average Price of Key Manufacturers (2016-2021)
Manufacturers Nuclear Medicine Production Sites and Area Served
Manufacturers Nuclear Medicine Product Type
Global Nuclear Medicine Sales Volume by Region (2016-2021)
Global Nuclear Medicine Sales Volume Market Share by Region (2016-2021)
Global Nuclear Medicine Sales Revenue by Region (2016-2021)
Global Nuclear Medicine Sales Revenue Market Share by Region (2016-2021)
North America Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Nuclear Medicine Consumption by Countries (2016-2021)
East Asia Nuclear Medicine Consumption by Countries (2016-2021)
Europe Nuclear Medicine Consumption by Region (2016-2021)
South Asia Nuclear Medicine Consumption by Countries (2016-2021)
Southeast Asia Nuclear Medicine Consumption by Countries (2016-2021)
Middle East Nuclear Medicine Consumption by Countries (2016-2021)
Africa Nuclear Medicine Consumption by Countries (2016-2021)
Oceania Nuclear Medicine Consumption by Countries (2016-2021)
South America Nuclear Medicine Consumption by Countries (2016-2021)
Rest of the World Nuclear Medicine Consumption by Countries (2016-2021)
Global Nuclear Medicine Sales Volume by Type (2016-2021)
Global Nuclear Medicine Sales Volume Market Share by Type (2016-2021)
Global Nuclear Medicine Sales Revenue by Type (2016-2021)
Global Nuclear Medicine Sales Revenue Share by Type (2016-2021)
Global Nuclear Medicine Sales Price by Type (2016-2021)
Global Nuclear Medicine Consumption Volume by Application (2016-2021)
Global Nuclear Medicine Consumption Volume Market Share by Application (2016-2021)
Global Nuclear Medicine Consumption Value by Application (2016-2021)
Global Nuclear Medicine Consumption Value Market Share by Application (2016-2021)
GE Healthcare Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bracco Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Mallinckrodt Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Lantheus Medical Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bayer Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Triad Isotopes Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Nordion Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Jubilant Pharma Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eli Lilly Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
SIEMENS Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
China Isotope & Radiation Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Dongcheng Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Nuclear Medicine Distributors List
Nuclear Medicine Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Nuclear Medicine Production Forecast by Region (2022-2027)
Global Nuclear Medicine Sales Volume Forecast by Type (2022-2027)
Global Nuclear Medicine Sales Volume Market Share Forecast by Type (2022-2027)
Global Nuclear Medicine Sales Revenue Forecast by Type (2022-2027)
Global Nuclear Medicine Sales Revenue Market Share Forecast by Type (2022-2027)
Global Nuclear Medicine Sales Price Forecast by Type (2022-2027)
Global Nuclear Medicine Consumption Volume Forecast by Application (2022-2027)
Global Nuclear Medicine Consumption Value Forecast by Application (2022-2027)
North America Nuclear Medicine Consumption Forecast 2022-2027 by Country
East Asia Nuclear Medicine Consumption Forecast 2022-2027 by Country
Europe Nuclear Medicine Consumption Forecast 2022-2027 by Country
South Asia Nuclear Medicine Consumption Forecast 2022-2027 by Country
Southeast Asia Nuclear Medicine Consumption Forecast 2022-2027 by Country
Middle East Nuclear Medicine Consumption Forecast 2022-2027 by Country
Africa Nuclear Medicine Consumption Forecast 2022-2027 by Country
Oceania Nuclear Medicine Consumption Forecast 2022-2027 by Country
South America Nuclear Medicine Consumption Forecast 2022-2027 by Country
Rest of the world Nuclear Medicine Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Nuclear Medicine Market Share by Type: 2021 VS 2027
Tc-99 Features
I-123/131 Features
In-111 Features
Xe-133 Features
Th-201 Features
Ga-67 Features
Global Nuclear Medicine Market Share by Application: 2021 VS 2027
Diagnostic Case Studies
Therapeutic Case Studies
Nuclear Medicine Report Years Considered
Global Nuclear Medicine Market Status and Outlook (2016-2027)
North America Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
East Asia Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Europe Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South Asia Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South America Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Middle East Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Africa Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Oceania Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South America Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
North America Nuclear Medicine Sales Volume Growth Rate (2016-2021)
East Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Europe Nuclear Medicine Sales Volume Growth Rate (2016-2021)
South Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Southeast Asia Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Middle East Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Africa Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Oceania Nuclear Medicine Sales Volume Growth Rate (2016-2021)
South America Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Rest of the World Nuclear Medicine Sales Volume Growth Rate (2016-2021)
North America Nuclear Medicine Consumption and Growth Rate (2016-2021)
North America Nuclear Medicine Consumption Market Share by Countries in 2021
United States Nuclear Medicine Consumption and Growth Rate (2016-2021)
Canada Nuclear Medicine Consumption and Growth Rate (2016-2021)
Mexico Nuclear Medicine Consumption and Growth Rate (2016-2021)
East Asia Nuclear Medicine Consumption and Growth Rate (2016-2021)
East Asia Nuclear Medicine Consumption Market Share by Countries in 2021
China Nuclear Medicine Consumption and Growth Rate (2016-2021)
Japan Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Korea Nuclear Medicine Consumption and Growth Rate (2016-2021)
Europe Nuclear Medicine Consumption and Growth Rate
Europe Nuclear Medicine Consumption Market Share by Region in 2021
Germany Nuclear Medicine Consumption and Growth Rate (2016-2021)
United Kingdom Nuclear Medicine Consumption and Growth Rate (2016-2021)
France Nuclear Medicine Consumption and Growth Rate (2016-2021)
Italy Nuclear Medicine Consumption and Growth Rate (2016-2021)
Russia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Spain Nuclear Medicine Consumption and Growth Rate (2016-2021)
Netherlands Nuclear Medicine Consumption and Growth Rate (2016-2021)
Switzerland Nuclear Medicine Consumption and Growth Rate (2016-2021)
Poland Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Asia Nuclear Medicine Consumption and Growth Rate
South Asia Nuclear Medicine Consumption Market Share by Countries in 2021
India Nuclear Medicine Consumption and Growth Rate (2016-2021)
Pakistan Nuclear Medicine Consumption and Growth Rate (2016-2021)
Bangladesh Nuclear Medicine Consumption and Growth Rate (2016-2021)
Southeast Asia Nuclear Medicine Consumption and Growth Rate
Southeast Asia Nuclear Medicine Consumption Market Share by Countries in 2021
Indonesia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Thailand Nuclear Medicine Consumption and Growth Rate (2016-2021)
Singapore Nuclear Medicine Consumption and Growth Rate (2016-2021)
Malaysia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Philippines Nuclear Medicine Consumption and Growth Rate (2016-2021)
Vietnam Nuclear Medicine Consumption and Growth Rate (2016-2021)
Myanmar Nuclear Medicine Consumption and Growth Rate (2016-2021)
Middle East Nuclear Medicine Consumption and Growth Rate
Middle East Nuclear Medicine Consumption Market Share by Countries in 2021
Turkey Nuclear Medicine Consumption and Growth Rate (2016-2021)
Saudi Arabia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Iran Nuclear Medicine Consumption and Growth Rate (2016-2021)
United Arab Emirates Nuclear Medicine Consumption and Growth Rate (2016-2021)
Israel Nuclear Medicine Consumption and Growth Rate (2016-2021)
Iraq Nuclear Medicine Consumption and Growth Rate (2016-2021)
Qatar Nuclear Medicine Consumption and Growth Rate (2016-2021)
Kuwait Nuclear Medicine Consumption and Growth Rate (2016-2021)
Oman Nuclear Medicine Consumption and Growth Rate (2016-2021)
Africa Nuclear Medicine Consumption and Growth Rate
Africa Nuclear Medicine Consumption Market Share by Countries in 2021
Nigeria Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Africa Nuclear Medicine Consumption and Growth Rate (2016-2021)
Egypt Nuclear Medicine Consumption and Growth Rate (2016-2021)
Algeria Nuclear Medicine Consumption and Growth Rate (2016-2021)
Morocco Nuclear Medicine Consumption and Growth Rate (2016-2021)
Oceania Nuclear Medicine Consumption and Growth Rate
Oceania Nuclear Medicine Consumption Market Share by Countries in 2021
Australia Nuclear Medicine Consumption and Growth Rate (2016-2021)
New Zealand Nuclear Medicine Consumption and Growth Rate (2016-2021)
South America Nuclear Medicine Consumption and Growth Rate
South America Nuclear Medicine Consumption Market Share by Countries in 2021
Brazil Nuclear Medicine Consumption and Growth Rate (2016-2021)
Argentina Nuclear Medicine Consumption and Growth Rate (2016-2021)
Columbia Nuclear Medicine Consumption and Growth Rate (2016-2021)
Chile Nuclear Medicine Consumption and Growth Rate (2016-2021)
Venezuelal Nuclear Medicine Consumption and Growth Rate (2016-2021)
Peru Nuclear Medicine Consumption and Growth Rate (2016-2021)
Puerto Rico Nuclear Medicine Consumption and Growth Rate (2016-2021)
Ecuador Nuclear Medicine Consumption and Growth Rate (2016-2021)
Rest of the World Nuclear Medicine Consumption and Growth Rate
Rest of the World Nuclear Medicine Consumption Market Share by Countries in 2021
Kazakhstan Nuclear Medicine Consumption and Growth Rate (2016-2021)
Sales Market Share of Nuclear Medicine by Type in 2021
Sales Revenue Market Share of Nuclear Medicine by Type in 2021
Global Nuclear Medicine Consumption Volume Market Share by Application in 2021
GE Healthcare Nuclear Medicine Product Specification
Bracco Imaging Nuclear Medicine Product Specification
Mallinckrodt Nuclear Medicine Product Specification
Lantheus Medical Imaging Nuclear Medicine Product Specification
Bayer Nuclear Medicine Product Specification
Triad Isotopes Nuclear Medicine Product Specification
Nordion Nuclear Medicine Product Specification
Jubilant Pharma Nuclear Medicine Product Specification
Eli Lilly Nuclear Medicine Product Specification
SIEMENS Nuclear Medicine Product Specification
China Isotope & Radiation Nuclear Medicine Product Specification
Dongcheng Nuclear Medicine Product Specification
Manufacturing Cost Structure of Nuclear Medicine
Manufacturing Process Analysis of Nuclear Medicine
Nuclear Medicine Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Nuclear Medicine Production Capacity Growth Rate Forecast (2022-2027)
Global Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Global Nuclear Medicine Price and Trend Forecast (2016-2027)
North America Nuclear Medicine Production Growth Rate Forecast (2022-2027)
North America Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
East Asia Nuclear Medicine Production Growth Rate Forecast (2022-2027)
East Asia Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Europe Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Europe Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
South Asia Nuclear Medicine Production Growth Rate Forecast (2022-2027)
South Asia Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Southeast Asia Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Middle East Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Middle East Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Africa Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Africa Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Oceania Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Oceania Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
South America Nuclear Medicine Production Growth Rate Forecast (2022-2027)
South America Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Rest of the World Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Rest of the World Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
North America Nuclear Medicine Consumption Forecast 2022-2027
East Asia Nuclear Medicine Consumption Forecast 2022-2027
Europe Nuclear Medicine Consumption Forecast 2022-2027
South Asia Nuclear Medicine Consumption Forecast 2022-2027
Southeast Asia Nuclear Medicine Consumption Forecast 2022-2027
Middle East Nuclear Medicine Consumption Forecast 2022-2027
Africa Nuclear Medicine Consumption Forecast 2022-2027
Oceania Nuclear Medicine Consumption Forecast 2022-2027
South America Nuclear Medicine Consumption Forecast 2022-2027
Rest of the world Nuclear Medicine Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
